AbbVie Announces Global Resolution of HUMIRA® (adalimumab) Patent Disputes with Fresenius Kabi
Thursday, October 18, 2018 DrugName : adalimumab AbbVie announced global resolution of all intellectual property-related litigation with Fresenius Kabi over
Read More